Position in DERM
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$49,408
-$154,906 QoQ
Shares Held
10,535
-60.2% QoQ
Ownership
0.038%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
8 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in DERM Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026MORGAN STANLEY holds $4,148,184,090 across 73 Drug Manufacturers - Specialty & Generic names. DERM ranks #57 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
14,145,735 | $1,672,167,321 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
409,288 | $242,699,592 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
7,426,253 | $223,678,734 | |
| 4 | VTRS |
Viatris Inc
|
16,089,939 | $217,375,067 | |
| 5 | HLN |
Haleon plc
|
19,166,253 | $191,854,187 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
8,889,088 | $184,537,462 | |
| 7 | NBIX |
Neurocrine Biosciences Inc
|
1,219,196 | $160,616,870 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
6,417,527 | $153,571,413 |
All Filings in DERM
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $49,408 | 10,535 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $204,314 | 26,500 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $147,610 | 20,732 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $372,742 | 51,914 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $83,738 | 14,193 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $37,927 | 9,700 | Shares | Defined | 2025-05-15 | |
| 2024-03-31 | $2,024 | 550 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $1,152 | 200 | Shares | Defined | 2024-08-16 | |
| No filing history on record for this holder in this stock. | ||||||